General Information of Drug (ID: DM36HBS)

Drug Name
ALXN1101 Drug Info
Indication
Disease Entry ICD 11 Status REF
Molybdenum cofactor deficiency 5B5K.A Phase 2/3 [1]
Cross-matching ID
PubChem CID
135463437
TTD Drug ID
DM36HBS

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Cyclic pyranopterin monophosphate synthase (MOCS1) TTH13AB MOCS1_HUMAN Modulator [2]

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2 ClinicalTrials.gov (NCT02047461) Safety & Efficacy Study of ALXN1101 in Pediatric Patients With MoCD Type A Currently Treated With rcPMP. U.S. National Institutes of Health.